The Nora District is gearing up for some major projects as its retail and restaurant phase is already operational, with Nora ...
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
Shanghai has unveiled a comprehensive blueprint for its next phase of economic and social development, outlining key goals, ...
Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) provides shareholders a corporate ...
Rheinmetall and MBDA plan to form a joint venture in 2026 to develop naval laser weapon systems, following successful German ...
Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...
Okyo Pharma appointed Robert J. Dempsey to serve as the company’s next CEO, according to a press release.
LB Pharmaceuticals, Inc ('LB Pharmaceuticals” or the 'Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company ...
By ending its agreement with ImmuneOnco, Instil is also handing back the other asset from the licensing deal: IMM27M, a next-gen anti-CTLA-4 antibody that ImmuneOnco had taken into phase 1 trials as a ...
A new 1.8 million square foot Costco distribution depot is coming to Port St. Lucie in March, bringing nearly 400 jobs to the city with an average salary of about $55,000 per year.